Cullinan Oncology Inc
NASDAQ:CGEM
Cullinan Oncology Inc
Other Items
Cullinan Oncology Inc
Other Items Peer Comparison
Competitive Other Items Analysis
Latest Figures & CAGR of Competitors
Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Cullinan Oncology Inc
NASDAQ:CGEM
|
Other Items
$36m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Other Items
-$10.3B
|
CAGR 3-Years
35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-28%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Items
-$3.1B
|
CAGR 3-Years
42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Items
-$26.8B
|
CAGR 3-Years
-77%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Items
-$3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-79%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Items
-$3.8B
|
CAGR 3-Years
-212%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-32%
|
See Also
What is Cullinan Oncology Inc's Other Items?
Other Items
36m
USD
Based on the financial report for Dec 31, 2023, Cullinan Oncology Inc's Other Items amounts to 36m USD.
What is Cullinan Oncology Inc's Other Items growth rate?
Other Items CAGR 1Y
-86%
Over the last year, the Other Items growth was -86%.